FDA Law Blog: Biosimilars

MAY 25, 2023

The conference will highlight hot topics affecting the healthcare and life sciences industries. Join attendees from around the globe at the IBA’s World Life Sciences Conference in Washington, DC. We are honored to have keynote addresses from DOJ and FDA officials. Hyman Phelps & McNamara, P.C.

45

45

FDA Law Blog: Biosimilars

FEBRUARY 26, 2024

Walsh among an elite panel discussing “Around the World Hot Topics” – a session dedicated to exploring recent enforcement trends, regulator expectations, and best practices in white-collar crime law. The event is set to take place from March 4-6, 2024, in San Francisco, California.

59

59

Drug Channels

OCTOBER 15, 2023

View the agenda the 2023 PBM Contracting Summit to see the complete picture – the program, speakers, and more, and visit www.informaconnect.com/pbm-contracting for further details and to register. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to November 10, 2023.*

Drug Pricing 56

Drug Pricing Biosimilars 56

Pharma in Brief

JANUARY 10, 2024

The Court found that it was “not in the public interest” to require patients taking the infringing biosimilar to switch medications, as the infringing product was “the only 80 mg/0.8 Areas to watch in 2024 We expect the following to be hot topics in the Canadian pharma space in 2024: US mass drug imports from Canada.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

pharmaphorum

OCTOBER 7, 2020

Pepa has 15 years of combined experience in Regulatory Affairs (CMC) and multiple aspects of drug development and research and has participated in the approval of 15 original and biosimilar biologic license applications, focusing on microbiology product quality and sterility assurance aspects.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 52